AstraZeneca's Alexion Pharmaceuticals was sued in Massachusetts federal court on Wednesday for allegedly misusing its patents ...

AstraZeneca and Honeywell are developing MDIs that will use a new propellant called HFO-1234ze, which, according to the company, has 99.9% less Global Warming Potential (GWP) than existing ...

AstraZeneca is a company with a turbulent history but, for now, a promising future. We take a look at the company's story, from its creation as a merger of two equals, to its recent major ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Guillain-Barré syndrome (GBS) is a rare immune-mediated disorder of the peripheral ... However, she had her first intramuscular dose of the Oxford/AstraZeneca COVID-19 vaccine 11 days prior to her ...

AstraZeneca Pharma India Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 21,286.25 Crore) operating in Pharmaceuticals sector. AstraZeneca Pharma India Ltd. key ...

At close: April 11 at 5:29:57 PM GMT+2 ...

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...

Aims Guillain-Barré syndrome (GBS) is an autoimmune acute inflammatory polyradiculoneuropathy. Intravenous immunoglobulins (IVIG) are usually the first choice of treatment. At present, limited ...